Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
Sep. 30, 2014
Dec. 31, 2013
Current Assets    
Cash and cash equivalents $ 440,837 $ 3,672,877
Marketable securities 16,287 15,731
Restricted cash 555,842 555,008
Accounts receivable - project revenue and reimbursable project costs 138,026 425,916
Prepaid expenses & other current assets 300,398 288,939
Total Current Assets 1,451,390 4,958,471
Property Plant and Equipment -net 0 0
Other Assets    
Patent costs - net 801,447 699,168
Total Assets 2,252,837 5,657,639
Current Liabilities    
Accounts payable and accrued liabilities 389,404 476,628
Total Current Liabilities 389,404 476,628
Stockholders' Equity    
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding 0 0
Common stock, $0.001 par value, 500,000,000 authorized, 15,204,358 shares outstanding and 15,057,243 shares outstanding at September 30, 2014 and December 31, 2013, respectively 15,204 15,057
Additional paid in capital - stock and stock equivalents 76,776,381 76,243,764
Deficit (74,928,152) (71,077,810)
Total Stockholders' Equity 1,863,433 5,181,011
Total Liabilities and Stockholders' Equity $ 2,252,837 $ 5,657,639